首页> 外国专利> Regulation of gut microbiota in Huntington's disease and Rett syndrome

Regulation of gut microbiota in Huntington's disease and Rett syndrome

机译:肠道菌群在亨廷顿氏病和瑞特综合征中的调控

摘要

Some of the embodiments described herein reduce the likelihood of developing one or more symptoms associated with Rett syndrome or Huntington's disease, methods, compositions for delaying the onset of the symptoms or alleviating the symptoms. Related to goods and / or uses. Without being limited to a particular theory, it is believed that modulating gut microbiota can affect the symptoms of Rett syndrome and Huntington's disease. By administering a composition or combination product comprising, consisting essentially of, or consisting of, bacteria and / or antibiotics to a subject in need of the composition or combination product, resulting in Rett syndrome or Huntington's disease. The likelihood of developing the symptoms of the disease can be reduced, the onset of the symptoms can be delayed, or the symptoms can be alleviated.
机译:本文所述的一些实施方案降低了发展出与雷特综合征或亨廷顿氏病相关的一种或多种症状的可能性,用于延迟症状发作或减轻症状的方法,组合物。与商品和/或用途有关。在不限于特定理论的情况下,据信调节肠道菌群可以影响Rett综合征和亨廷顿氏病的症状。通过将包含细菌和/或抗生素,基本上由细菌和/或抗生素组成或由细菌和/或抗生素组成的组合物或组合产品施用于需要该组合物或组合产品的受试者,从而导致雷特综合征或亨廷顿氏病。可以减少出现疾病症状的可能性,可以延迟症状的发作或可以缓解症状。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号